United States

Unlocking Value Growth in the Biopharmaceutical Market

Nov 25, 2014
From the Healthcare & Life Sciences Institute

Delivering "winning" performance in today’s biopharmaceutical landscape requires making the right therapeutic area, geography, and physician/hospital participation choices as well as determining how to deliver more stakeholder benefit than the competition, while getting paid for it. Companies that excel at doing this can be expected to deliver strong profitable growth performance, whether they have chosen to focus on branded Rx or diversify beyond branded Rx into other businesses.